EPO Patents = 3

Forward Citations = 0

Loading Chart...

27 inventors (with patents filed for the assignee):

Zhirong Zhang (3 out of 3 patents)

Yan Zhang (2 out of 5 patents)

Xiaoqing Bai (2 out of 2 patents)

4. Jian Li (1 out of 202 patents)

5. Shuhui Chen (1 out of 200 patents)

6. Zhengxia Chen (1 out of 18 patents)

7. Meibi Dai (1 out of 12 patents)

8. Wenju Li (1 out of 2 patents)

9. Ling Zhang (1 out of 1 patent)

10. Jianbo Li (1 out of 2 patents)

11. Meiling Zhou (1 out of 1 patent)

12. Tao Gong (1 out of 1 patent)

13. Xu Song (1 out of 3 patents)

14. Tijia Chen (1 out of 1 patent)

15. Yao Fu (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 12419874 - GLP-1R agonist compound and use thereof (2025-09-23),

2. 11161817 - Quinoline derivative and use thereof as tyrosine kinase inhibitor (2021-11-02),

3. 11149005 - Organic amine ester derivative drug of 2-(α-hydroxypentyl)benzoic acid (2021-10-19),

4. 10639295 - Podophyllotoxin derivative with 4-position nitrogen substitution and preparation method and application thereof (2020-05-05),

5. 10428114 - Type polypeptide targeting tumours (2019-10-01),

Yaopharma Co., Ltd. is a global pharmaceutical company specializing in the research, development, and production of high-quality and cost-effective pharmaceutical products. With a focus on innovation and customer satisfaction, Yaopharma is committed to providing safe and effective medications to patients worldwide. The company's diverse product portfolio includes a wide range of prescription and over-the-counter drugs across various therapeutic categories.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

5 Patents

#51 in Chongqing

#4,601 in China

Chongqing, China

Yaopharma Co., Ltd.